منابع مشابه
Evaluating the Role of Corticotropin Receptors on Feed Intake Using Melanocortin Receptor Agonists in Neonatal Broilers
Evidence from animal studies suggests corticotrophin and melanocortin systems have regulatory role in feeding system in avian, but there is no evidence for their interaction. In this survey three experiments designed to investigate the role of corticotrophin receptors on food intake using melanocortin receptors agonist M3 and M4 in neonatal chicken (each experiment includes 4 groups and 11 bird...
متن کاملMolecular evolution of GPCRs: Melanocortin/melanocortin receptors.
The melanocortin receptors (MCRs) are a family of G protein-coupled receptors that are activated by melanocortin ligands derived from the proprotein, proopiomelanocortin (POMC). During the radiation of the gnathostomes, the five receptors have become functionally segregated (i.e. melanocortin 1 receptor (MC1R), pigmentation regulation; MC2R, glucocorticoid synthesis; MC3R and MC4R, energy homeo...
متن کاملMelanocortin 1 receptor agonists reduce proteinuria.
Membranous nephropathy is one of the most common causes of nephrotic syndrome in adults. Recent reports suggest that treatment with adrenocorticotropic hormone (ACTH) reduces proteinuria, but the mechanism of action is unknown. Here, we identified gene expression of the melanocortin receptor MC1R in podocytes, glomerular endothelial cells, mesangial cells, and tubular epithelial cells. Podocyte...
متن کاملEffects of Melanocortin 1 Receptor Agonists in Experimental Nephropathies
Nephrotic syndrome, characterized by massive proteinuria, is caused by a large group of diseases including membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS). Although the underlying mechanisms are beginning to unravel, therapy is unspecific and far from efficient. It has been suggested that adrenocorticotropic hormone (ACTH) has beneficial effects in patients with MN and...
متن کاملMelanocortin-4 receptor agonists for the treatment of obesity.
The identification of a highly efficacious anti-obesity agent remains an illusive goal. While many avenues of investigation have been pursued, none of the existing compounds claim much more than a 10% reduction in weight in humans (over a one year period with diet and exercise). Nonetheless, the potential reward for fulfilling this unmet medical need has kept interest levels high in the researc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bioorganic & Medicinal Chemistry Letters
سال: 2009
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2009.07.025